Product Information

TRI-LO-MARZIA TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.1106 per EA under NDC 68180083773. Its NADAC has been published 355 times since Feb 5, 2020.

FDA first approved this application on Jun 25, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TRI-LO-MARZIA TABLET

norgestimate and ethinyl estradiol
$0.1106per EA

NDC

68180083773

Classification

Generic

Dosage Form

KIT

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA200541

FDA Approved

6/25/2012

TE Code

AB

On Market Since

1/8/2020

Price Statistics

The NADAC for TRI-LO-MARZIA TABLET has been published 355 times since Feb 5, 2020, and over the history we have for it it has declined 47.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1106 per EA
All-time high$0.2385 (Aug 12, 2020)
All-time low$0.0903 (Nov 20, 2024)
52-week high$0.1148
52-week low$0.1046
Median price$0.1483
Average price$0.1474
Largest weekly change-27.8% (Apr 17, 2024)
Weeks tracked355
Tracking sinceFeb 5, 2020

Price History

1W

+2.0%

1M

+2.3%

3M

+2.1%

6M

+3.1%

1Y

-1.1%

3Y

-17.6%

5Y

-31.9%

All

-47.5%

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TRI-LO-MARZIA TABLET?

The current National Average Drug Acquisition Cost (NADAC) for TRI-LO-MARZIA TABLET, manufactured by Lupin Pharmaceuticals Inc., is $0.1106 per EA (NDC 68180083773), effective Nov 18, 2026.

How has the price of TRI-LO-MARZIA TABLET changed over time?

Over the history we have for it, the NADAC for TRI-LO-MARZIA TABLET has declined 47.5%. It has been tracked across 355 weekly CMS publications since Feb 5, 2020.

What are the highest and lowest recorded NADAC prices for TRI-LO-MARZIA TABLET?

Since Feb 5, 2020, the NADAC for TRI-LO-MARZIA TABLET has ranged from a low of $0.0903 (Nov 20, 2024) to a high of $0.2385 (Aug 12, 2020), with a median of $0.1483 per EA.

Are there cheaper alternatives to TRI-LO-MARZIA TABLET?

Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MILI 0.25-0.035 MG TABLET, is $0.1067 per EA — about 3% below TRI-LO-MARZIA TABLET.

Who manufactures TRI-LO-MARZIA TABLET?

TRI-LO-MARZIA TABLET (NDC 68180083773) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.